Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03011814
Title Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors City of Hope Medical Center

peripheral T-cell lymphoma

cutaneous T cell lymphoma

Sezary's disease

mycosis fungoides



Durvalumab + Lenalidomide

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.